Senior Director, Clinical Supply Chain
Structure Therapeutics
Summary
The Senior Director, Clinical Supply Chain will lead the global strategy, planning, and execution of clinical supplies across our small molecule pipeline. Operating within a fast-paced, outsourced biotech model, this role ensures uninterrupted, compliant, and cost-effective delivery of Investigational Medicinal Product (IMP) to global clinical sites. This position will provide leadership and direction on a cross functional basis to ensure that all clinical trials have timely and adequate supply for administration to study participants. This is both a strategic and execution focused role requiring someone to see the big picture, plan, and roll up their sleeves and get things done. The Senior Director will partner closely with Clinical Operations, Clinical Science, Program Management, Quality, Regulatory, CMC, Finance, and externally with Clinical Service Providers (e.g., CMOs, CROs, IP Drug Depot) to scale our supply chain infrastructure from late-stage clinical trials through NDA/MAA filing and commercial launch readiness.
Job description
Position Summary
The Senior Director, Clinical Supply Chain will lead the global strategy, planning, and execution of clinical supplies across our small molecule pipeline. Operating within a fast-paced, outsourced biotech model, this role ensures uninterrupted, compliant, and cost-effective delivery of Investigational Medicinal Product (IMP) to global clinical sites. This position will provide leadership and direction on a cross functional basis to ensure that all clinical trials have timely and adequate supply for administration to study participants. This is both a strategic and execution focused role requiring someone to see the big picture, plan, and roll up their sleeves and get things done. The Senior Director will partner closely with Clinical Operations, Clinical Science, Program Management, Quality, Regulatory, CMC, Finance, and externally with Clinical Service Providers (e.g., CMOs, CROs, IP Drug Depot) to scale our supply chain infrastructure from late-stage clinical trials through NDA/MAA filing and commercial launch readiness.
Job Responsibilities
Strategic Leadership & Late-Stage Planning
- Clinical supply management: Leads and manages clinical supply and logistics activities, including demand forecasting and supply planning, IRT start-up through study closure, label generation and approval, packaging and labeling operations, release and distribution, temperature excursion, expiry extension, drug return and destruction records, and inventory management
- Global Supply Strategy: Develop and execute end-to-end clinical supply chain strategies across Phase 1–3 small molecule programs, ensuring alignment with clinical enrollment forecasts and regulatory timelines
- Commercial Transition & Launch Readiness: Partner with CMC, Manufacturing, and Commercial teams to manage late-stage scale-up, registration batches, and the seamless transition from clinical supply to commercial launch
- Budget & Risk Management: Own program- and protocol-level clinical supply budgets, forecasting API, drug product, comparator, and packaging needs while proactively identifying and mitigating global supply chain risks
End-to-End Clinical Operations & Logistics
- Packaging, Labeling & Distribution: Oversee global packaging, primary/secondary labeling (including country-specific regulatory booklet labels), cold/controlled ambient storage, distribution, returns, and destruction
- Global Trade & Depot Strategy: Design and manage international depot networks, import/export compliance, customs clearance, and QP release workflows across North America, Europe, APAC, and other regions
- IRT / IxRS Oversight: Lead Interactive Response Technology (IRT/IVRS/IWRS) strategy, user acceptance testing (UAT), drug supply algorithms, and ongoing inventory optimization to minimize overage and prevent stockouts
Vendor & Cross-Functional Governance
- CDMO & Vendor Management: Select, negotiate contracts with, and manage performance of external clinical packaging/labeling vendors, global depots, couriers, and IRT providers
- Cross-Functional Alignment: Serve as the primary Clinical Supply representative on Global Program Teams, partnering with Clinical Operations, Biometrics, Quality Assurance, and Regulatory Affairs on protocol design, pharmacy manuals, and IND/IMPD/NDA submissions
- Team Leadership & Systems: Build, mentor, and develop high-performing clinical supply professionals while implementing scalable SOPs, quality systems, and demand-planning tools
Quality, Compliance & Team Development
- Ensure all clinical supply operations strictly adhere to cGMP, GDP, GCP, and global regulatory guidelines
- Author and review relevant CMC and supply chain sections for regulatory filings (IND, IMPD, NDA/MAA) and inspect clinical protocols, pharmacy manuals, and batch records
- Build, mentor, and lead a high-performing clinical supply team, establishing scalable SOPs, governance frameworks, and digital planning tools
Requirements
- Bachelor's degree in Supply Chain Management, Pharmaceutical Sciences, Chemistry, Engineering, or a related life sciences discipline required
- Advanced degree (MS, MBA, or PharmD) or APICS certification preferred
- 12–15+ years of progressive experience in pharmaceutical/biotech supply chain
- At least 5–7 years in a leadership role managing global clinical supplies
- Proven track record supporting late-stage (Phase 3) small molecule clinical trials, including solid oral dosage packaging, blinding, global comparator sourcing, and commercial launch preparation
- Deep expertise in IRT/IXRS management, demand forecasting software, global cold/controlled-room-temperature logistics, and cGMP/GDP regulations
- Extensive experience operating within a virtual or heavily outsourced biotech model, managing global CDMO and depot networks
- Exceptional cross-functional communication, executive presence, and problem-solving abilities in a fast-paced, milestone-driven environment
- 5 - 10% travel required
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Unlimited PTO
- Paid Holidays
- Winter Shutdown
- Annual Performance Bonus
- New Hire Equity
- Performance-Based Equity
Company overview
Structure Therapeutics is a clinical-stage global biopharmaceutical company focused on discovering and developing innovative oral small molecule therapeutics for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Founded in 2017 and headquartered in South San Francisco, California with operations in Shanghai, China, the company leverages its next-generation structure-based drug discovery platform to build a robust pipeline targeting G-protein coupled receptors (GPCRs). Structure Therapeutics' lead programs include aleniglipron, an oral small molecule GLP-1 receptor agonist for obesity treatment currently in Phase 2b clinical trials, and ACCG-2671, an oral small molecule amylin receptor agonist entering Phase 1 studies. The company's approach aims to overcome the limitations of traditional biologic and peptide therapies by developing accessible oral treatments that can reach more patients worldwide. Structure Therapeutics is publicly traded on NASDAQ under the ticker symbol GPCR and maintains a workforce of 51-200 employees dedicated to advancing novel therapeutics for chronic diseases including obesity, diabetes, and cardiovascular conditions.